ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag culture ecology opinion funding cancer

Special Report
lone birch tree growing sideways in a field
Amid the Terror of War, Efforts to Keep Science Alive in Ukraine
Katarina Zimmer | Mar 28, 2022 | 10+ min read
Ukrainian scientists and universities face extraordinary challenges as the Russian invasion continues.
An illustration of flowers in the shape of the female reproductive tract
Uterus Transplants Hit the Clinic
Jef Akst | Aug 1, 2021 | 10+ min read
With human research trials resulting in dozens of successful deliveries in the US and abroad, doctors move toward offering the surgery clinically, while working to learn all they can about uterine and transplant biology from the still-rare procedure.
2020 Top 10 Innovations
The Scientist | Dec 1, 2020 | 10+ min read
From a rapid molecular test for COVID-19 to tools that can characterize the antibodies produced in the plasma of patients recovering from the disease, this year’s winners reflect the research community’s shared focus in a challenging year.
Updated July 9
Track COVID-19 Vaccines Advancing Through Clinical Trials
The Scientist | Apr 7, 2020 | 10+ min read
Find the latest updates in this one-stop resource, including efficacy data and side effects of approved shots, as well as progress on new candidates entering human studies.
Alternative Medicines
The Scientist | Jul 1, 2012 | 10+ min read
As nonconventional medical treatments become increasingly mainstream, we take a look at the science behind some of the most popular.
What Price Salmon?
Steve Bunk | Jan 21, 2001 | 10+ min read
Credit: OAR/National Undersea Research Program (NURP) With the year-end release of a final decision on how to proceed toward saving wild Northwest salmon from extinction, the Clinton Administration left implementation of its long-awaited plan to the incoming Republicans. For years, researchers have struggled under a glare of media exposure to resolve a central issue: should four hydroelectric dams in Washington be removed to help save the fish? The conclusion is no, not yet, but a scientific div
Genetic Parasites and a Whole Lot More
Barry Palevitz | Oct 15, 2000 | 10+ min read
Photo: Ori Fragman, Hebrew University Hordeum spontaneum, the plant studied for BARE-1 retroelements. With genome sequences arriving almost as regularly as the morning paper, the public's attention is focused on genes--new genes to protect crops against pests; rogue genes that make bacteria resistant to antibiotics; faulty genes that, if fixed, could cure diseases such as muscular dystrophy. What many people don't realize is that genes account for only part of an organism's DNA, and in many c
Cloning Capsized?
Ted Agres | Aug 19, 2001 | 10+ min read
Biopharmaceutical researchers fear how pending federal legislation outlawing the cloning of human cells will restrict their abilities to find cures for major degenerative diseases.1,2 Some also see lawmakers impinging on established nonhuman cloning techniques essential for the discovery of new drugs and therapies. The source of all this worry? The US House of Representatives passed July 31 by a wide margin a bill (H.R. 2505) sponsored by Reps. David Weldon (R-Fla.) and Bart Stupak (D-Mich.) th
NASA Administrator Daniel Goldin Explains Timing, Purpose Of Big Changes At Agency
Daniel Goldin | Jan 10, 1993 | 8 min read
Editor's Note: Daniel Goldin, administrator of the National Aeronautics and Space Administration, was named to his $14 billion agency's top post seven months ago, having come from a position as vice president of TRW Inc.'s Space & Technology Group in Redondo Beach, Calif. In October, he initiated a series of major changes in the structure of NASA's space sciences research program. For example, Goldin has separated Mission to Planet Earth, the agency's Earth-observation satellite program, from t
Honorary Degrees: Controversial For Centuries
Barbara Spector | Jun 23, 1991 | 10+ min read
Last month, Roald Hoffmann, winner of the 1981 Nobel Prize in chemistry, added two more laurels to his already lengthy curriculum vitae when he accepted honorary degrees from the universities of Central Florida and Arizona. Top United States research institutions giving honorary degrees to scientists this spring include: University of Arizona, Tucson: Roald Hoffmann, John A. Newman Professor of Physical Science, Cornell University, winner of 1981 Nobel Prize in chemistry; Julius B. Richmon

Run a Search

ADVERTISEMENT